U.S. RESEARCH ROUNDUP-Nextera Energy, Nextpower, TKO Group

Reuters
2025/12/31
U.S. RESEARCH ROUNDUP-Nextera Energy, Nextpower, TKO Group

Dec 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Nextera Energy, Nextpower and TKO Group on Wednesday.

HIGHLIGHTS

* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $169 from $154

* $Nextera Energy Inc(NEE-N)$ NEE.N: Jefferies raises target price to $88 from $85

* Nextpower Inc NXT.O: Jefferies raises target price to $107 from $102

* Prologis Inc PLD.N: BTIG raises target price to $155 from $134

* TKO Group TKO.N: BTIG raises target price to $250 from $235

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $169 from $154

* Capsovision Inc CV.O: Benchmark raises target price to $14 from $5

* Community West Bancshares CWBC.O: KBW raises target price to $25 from $23

* Digitalbridge Group Inc DBRG.N: Truist Securities cuts to hold from buy

* Ekso Bionics Holdings Inc EKSO.O: H.C. Wainwright cuts to neutral rating

* Freeport-Mcmoran Inc FCX.N: Raymond James raises target price to $53 from $49

* Globalfoundries Inc GFS.O: Wedbush cuts target price to $40 from $42

* Globalfoundries Inc GFS.O: Wedbush cuts to neutral from outperform

* Marriott MAR.O: Argus Research raises target price to $370 from $310

* Nextera Energy Inc NEE.N: Jefferies raises target price to $88 from $85

* Nextpower Inc NXT.O: Jefferies raises target price to $107 from $102

* Prologis Inc PLD.N: BTIG raises target price to $155 from $134

* TKO Group TKO.N: BTIG raises target price to $250 from $235

* Vanda Pharmaceuticals Inc VNDA.O: B. Riley raises target price to $14 from $11

* Vanda Pharmaceuticals Inc VNDA.O: Jefferies raises target price to $7.5 from $5

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10